Charles Greg Guyer - Nov 12, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Nov 12, 2024
Transactions value $
-$347,243
Form type
4
Date filed
11/14/2024, 02:44 PM
Previous filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $3.08K +55 +0.07% $56.01 74.2K Oct 31, 2024 Direct F1
transaction BMRN Common Stock Sale -$350K -5.28K -7.11% $66.37 68.9K Nov 12, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
F2 The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.